Actively Recruiting
The Norwegian Antirheumatic Drug Register
Led by Diakonhjemmet Hospital · Updated on 2022-08-23
15000
Participants Needed
6
Research Sites
2017 weeks
Total Duration
On this page
Sponsors
D
Diakonhjemmet Hospital
Lead Sponsor
U
University Hospital of North Norway
Collaborating Sponsor
AI-Summary
What this Trial Is About
NOR-DMARD is a register-based longitudinal observational study of which the main objectives are to study the effectiveness of treatment of inflammatory joint diseases with biological disease modifying anti-rheumatic drugs (DMARDs) in clinical practice, by measuring disease activity, health related quality of life, function and joint damage, and to study the long-term safety of such treatment. Other objectives include the assessment of cost-effectiveness of treatment, to identify and and validate clinical, genetic and immunological predictors of efficacy and adverse events, to assess the impact of treatment with biological DMARDs on work participation and work productivity, to investigate different strategies for use of biological DMARDs, to assess the performance of different outcome measures, and to ensure a systematic and timely follow-up of patients treated with biological DMARDs.
CONDITIONS
Official Title
The Norwegian Antirheumatic Drug Register
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Age >18 years
- Diagnosis of rheumatoid arthritis, psoriatic arthritis, ankylosing spondylitis, spondyloarthritis, adult juvenile idiopathic arthritis, undifferentiated arthritis, or any other inflammatory arthritis
- Clinical indication to start a new treatment with a biological disease modifying anti-rheumatic drug or a kinase inhibitor
You will not qualify if you...
- Unwillingness or inability to give written informed consent
- Psychiatric or mental disorders, alcohol abuse or other substance abuse, language barriers, or other factors making adherence to the study protocol impossible
- Participation in blinded randomized clinical trials or other studies incompatible with this study protocol
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 6 locations
1
Vestre Viken HF Drammen Hospital
Drammen, Buskerud, Norway, 3004
Completed
2
Lillehammer Hospital for Rheumatic Diseases
Lillehammer, Oppland, Norway, 2609
Actively Recruiting
3
Førde Hospital
Førde, Sogn Og Fjordane, Norway, 6807
Actively Recruiting
4
St. Olavs Hospital
Trondheim, Sør-Trøndelag, Norway, 7006
Completed
5
University Hospital of Northern Norway
Tromsø, Troms, Norway, 9038
Actively Recruiting
6
Diakonhjemmet Hospital
Oslo, Norway, 0319
Actively Recruiting
Research Team
E
Eirik K Kristianslund, MD, PhD
CONTACT
E
Espen A Haavardsholm, MD, PhD
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
0
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here